Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | BMP2K | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | STON2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | ARNT | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | C17orf99 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-06 |
mRNA | JTB | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | AC015688.3 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | PRKCB | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
mRNA | HAX1 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |